2I9B image
Deposition Date 2006-09-05
Release Date 2007-01-02
Last Version Date 2024-10-30
Entry Detail
PDB ID:
2I9B
Keywords:
Title:
Crystal structure of ATF-urokinase receptor complex
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Urokinase-type plasminogen activator
Gene (Uniprot):PLAU
Chain IDs:A, B, C, D
Chain Length:145
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Urokinase plasminogen activator surface receptor
Gene (Uniprot):PLAUR
Mutations:N162Q, N172Q, N200Q, N233Q
Chain IDs:E, F, G, H
Chain Length:279
Number of Molecules:4
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN E ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
Structural basis of interaction between urokinase-type plasminogen activator and its receptor.
J.Mol.Biol. 363 482 495 (2006)
PMID: 16979660 DOI: 10.1016/j.jmb.2006.08.063

Abstact

Recent studies indicate that binding of the urokinase-type plasminogen activator (uPA) to its high-affinity receptor (uPAR) orchestrates uPAR interactions with other cellular components that play a pivotal role in diverse (patho-)physiological processes, including wound healing, angiogenesis, inflammation, and cancer metastasis. However, notwithstanding the wealth of biochemical data available describing the activities of uPAR, little is known about the exact mode of uPAR/uPA interactions or the presumed conformational changes that accompany uPA/uPAR engagement. Here, we report the crystal structure of soluble urokinase plasminogen activator receptor (suPAR), which contains the three domains of the wild-type receptor but lacks the cell-surface anchoring sequence, in complex with the amino-terminal fragment of urokinase-type plasminogen activator (ATF), at the resolution of 2.8 A. We report the 1.9 A crystal structure of free ATF. Our results provide a structural basis, represented by conformational changes induced in uPAR, for several published biochemical observations describing the nature of uPAR/uPA interactions and provide insight into mechanisms that may be responsible for the cellular responses induced by uPA binding.

Legend

Protein

Chemical

Disease

Primary Citation of related structures